LRRC24 Activators
LRRC24, or leucine-rich repeat-containing protein 24, is a member of the leucine-rich repeat (LRR) protein family, characterized by the presence of LRR domains. These domains are typically involved in protein-protein interactions, mediating the assembly of various signaling complexes. The LRR motif is a versatile structural framework that can accommodate substantial sequence variation and is implicated in a wide array of biological functions.
While the specific biological role of LRRC24 is not well-characterized, the presence of LRR domains suggests that it may function in cellular signaling pathways, possibly as a scaffolding protein that assembles key signaling proteins to facilitate effective signal transduction. The leucine-rich repeats could also enable LRRC24 to interact with other cellular proteins, potentially influencing processes like cell adhesion, migration, or the immune response, given the common roles of LRR-containing proteins.LRRC24's expression patterns across different tissues and developmental stages could provide insight into its physiological roles. If it is found to be highly expressed in certain cell types or under specific conditions, these contexts might offer clues to its function. Similarly, any associations between genetic variations or mutations in the LRRC24 gene and diseases could help to elucidate its biological significance.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which can activate PKA. PKA phosphorylation events may enhance LRRC24 activity by modifying proteins within its signaling complex. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentration, potentially activating calcium-dependent signaling pathways that might upregulate LRRC24 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC which is involved in numerous signaling cascades. PKC activation could lead to phosphorylation events that enhance the activity of LRRC24. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates cAMP-dependent pathways, potentially leading to the enhanced functional activity of LRRC24. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits protein phosphatases PP1 and PP2A, which can lead to increased phosphorylation and potential enhancement of LRRC24 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, possibly causing a shift in signaling pathways that could enhance the activity of LRRC24 through indirect mechanisms. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, raising intracellular calcium levels and potentially enhancing LRRC24 activity through calcium-dependent pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. By inhibiting PI3K, it may alter signaling pathways and indirectly enhance LRRC24 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that could modulate signaling pathways to indirectly enhance the activity of LRRC24. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAPK, potentially shifting signaling dynamics to pathways that enhance LRRC24 activity. | ||||||